#United States #New York #Gross Law Firm #Zenas BioPharma #ZBIO

Important Notice for Shareholders of Zenas BioPharma, Inc.

Introduction
As a shareholder in Zenas BioPharma, Inc. (NASDAQ: ZBIO), you may have important rights under the current circumstances that require your immediate attention. The Gross Law Firm wants to communicate significant details regarding a collective legal action in which you could be involved. Understanding the implications of this notice is crucial, especially if you've purchased shares during the specified class period.

Class Period Details
This legal action revolves around those who bought or acquired Zenas BioPharma securities during the time of the official registration statement and prospectus linked to the company’s initial public offering in September 2024. If you fall into this category, it is essential to reach out and understand the next steps.

During the described period, allegations have been raised against the company regarding the accuracy of their public disclosures. Specifically, it is claimed that Zenas BioPharma exaggerated how long it could sustain its operations based on its existing cash reserves and funds anticipated from the IPO. Consequently, it was alleged that company representatives might have issued misleading statements that misrepresented their financial health and operational capacity.

Legal Repercussions
These allegations are serious as they suggest negligence in preparing public statements which potentially mislead investors. If proven true, Zenas BioPharma could face significant consequences, and shareholders could be impacted profoundly.

Deadline to Act
The deadline for shareholders to step forward in this matter is June 16, 2025. It’s paramount that you do not delay registering your interest, as doing so might affect your ability to participate in the potential recovery from this legal action. You do not need to be appointed as a lead plaintiff to benefit from any potential recovery.

How to Get Involved
To begin the process, shareholders should click on the designated registration link provided by The Gross Law Firm. Upon registering, you will be enrolled in a portfolio monitoring program that ensures you receive updates throughout the duration of the case, thus keeping you informed about your rights and options in real-time.

Why Choose Gross Law Firm?
The Gross Law Firm is a reputable class action law firm recognized nationwide, dedicated to protecting investors' rights who believe they've suffered due to deceit, fraud, or unlawful business practices. Their mission emphasizes ensuring firms adhere to appropriate governance and corporate responsibility standards. They work relentlessly to recover losses for investors impacted by misinformation or lack of transparency from companies.

Final Thoughts
In conclusion, if you have purchased Zenas BioPharma stock during the specified class period, it is vital to act quickly. Engage with The Gross Law Firm to explore your rights and options without any obligation or cost associated with participation in this action. Your proactive response could be pivotal in influencing the outcome of your investment in ZBIO. For more information, refer to their contact details provided in the notice.

Contact Information

• - The Gross Law Firm
• - Address: 15 West 38th Street, 12th Floor, New York, NY, 10018
• - Email: [email protected]
• - Phone: (646) 453-8903

Protect your investments—act now to ensure your voice is heard in this critical situation.